Abstract
To avoid unnecessary surgeries, ultrasound-guided fine-needle aspiration biopsy (FNAB) is an effective and reliable procedure for the preoperative evaluation of thyroid nodules. However, there have been only a limited number of studies exploring the ability of preoperative FNAB to distinguish malignancy compared to postoperative histopathology in thyroid nodules larger than 4 cm. The aim of this study was to investigate the diagnostic accuracy of FNAB compared to postoperative histopathology in distinguishing malignancy in thyroid nodules larger than 4 cm. A single-center retrospective observational study was conducted at Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia, between January 2014 and December 2018. The sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy were calculated. A total of 83 patients were included in the study. The results showed that preoperative FNAB may have the ability to distinguish malignancy compared to postoperative histopathology. The sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy were 42.85%, 98.38%, 90.00%, 83.56%, and 84.33%, respectively. These data suggested that ultrasound-guided preoperative FNAB is a reliable diagnostic tool in the preoperative evaluation of thyroid nodules larger than 4 cm, but it has limited capability in distinguishing malignancies. In conclusion, although FNAB may be useful in reducing unnecessary surgeries, histopathology remains the preferred method for confirming malignancy in thyroid nodules.
Keywords: Fine-needle aspiration biopsy, histopathology, thyroid nodule, accuracy, sensitivity
Introduction
The availability of ultrasound-guided techniques allows the detection and aspiration of smaller and deep-seated thyroid nodules [1-3]. Although most thyroid nodules are benign, the prevalence of thyroid malignancy has recently increased dramatically up to a rate of 5%–20% [4]. The rising rates of thyroid nodules highlight the importance and urgency of identifying the malignancy precisely [5].
Fine-needle aspiration biopsy (FNAB) has long been considered the most important primary diagnostic tool in the evaluation of thyroid nodules due to its advantages, including simplicity, safety, cost-effectiveness, and high diagnostic specificity [2,6,7]. Reported sensitivity and specificity of thyroid FNAB typically range between 80% and 100% [2,3,8-10]. However, there is ongoing controversy regarding the accuracy of FNAB to exclude malignancy in nodules larger than 4 cm [5]. Studies have reported a high false negativity rate for FNAB, ranging from 10% to 50% [11]. Some studies recommend surgery for nodules larger than 4 cm regardless of FNAB results [5,11-17], while others assert the reliability of FNAB even in larger nodules [18-23].
Larger thyroid nodules are well-established to have a higher risk of cancer [12]. The gold standard for diagnosing malignancy status is a histological assessment of the surgically excised thyroid nodule, although it has inherent surgical risks [24]. FNAB aids clinicians in diagnosing the malignancy and deciding on thyroidectomy. Nevertheless, the increased morbidity and costs associated with unneeded thyroidectomy must be considered [25].
While FNAB is widely accepted and utilized for diagnosing thyroid nodules, the conflicting evidence has been reported in several studies [5,11-23], necessitates a comprehensive investigation into the diagnostic accuracy of FNAB compared to postoperative histopathology for large thyroid nodules. Therefore, this study aimed to provide diagnostic accuracy of FNAB compared to postoperative histopathology in detecting malignancy in thyroid nodules larger than 4 cm. The findings will aid therapeutic decision-making and could potentially decrease avoidable surgical procedures, morbidity, and costs.
Methods
Study design and setting
A single-center retrospective observational study was conducted at Dr. Zainoel Abidin Hospital, a tertiary hospital in Banda Aceh, Indonesia between January 2014 and December 2018. The study investigated the medical records of 567 patients who underwent both ultrasound-guided preoperative FNAB and postoperative histopathology. Total sampling was adopted, based on eligibility criteria, resulting in 83 qualified medical records. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy were determined using a fourfold table and the receiver operating characteristic (ROC) curve.
Eligibility criteria
The inclusion criteria are as follows: (1) diagnosed solid thyroid nodules larger than 4 cm based on histopathological and grayscale thyroid ultrasonography assessment; (2) normal thyroid stimulating hormone (TSH) serum level (0.25–5 µIU/mL); (3) age range 17–70 years old based on the medical record; and (4) had complete preoperative FNAB record. All patients who had undergone radioiodine therapy and recurrent or relapse thyroid carcinoma were excluded.
Data collection
FNAB cytology results were categorized using the Bethesda system for the classification of thyroid cytopathology [26]. Cytology classifications were compared to histologic diagnoses of the surgical specimens made by an anatomical pathologist with over ten years of expertise (R.K.K).
Statistical analysis
Sensitivity, specificity, PPV, NPV, and diagnostic accuracy were determined by comparing cytology results to histology results, which serve as the gold standard for malignancy detection. The fourfold table analysis and ROC curve were employed for these calculations.
Results
Characteristics of patients
The basic characteristics of the 83 patients with thyroid nodules larger than 4 cm are presented in Table 1. There were different proportions between gender and age between patients; the majority of patients (83.13%) were male, and the mean age was approximately 46–55 years old.
Table 1. Characteristics of patients with thyroid nodules larger than 4 cm included in the study.
| Patient characteristic | Total | |
|---|---|---|
| n | % | |
| Sex | ||
| Male | 69 | 83-3 |
| Female | 14 | 16.86 |
| Age (year) | ||
| 17-25 | 5 | 6.02 |
| 26-35 | 10 | 8.30 |
| 36-45 | 20 | 16.60 |
| 46-55 | 21 | 25.30 |
| 56-65 | 21 | 25.30 |
| >65 | 6 | 7.22 |
Characteristics of thyroid nodules based on FNAB and histopathology
Thyroid nodules were histopathologically detected following surgery. The outcome was classified as non-malignancy, non-neoplasm, or malignancy based on FNAB thyroid nodule characteristics and histopathologic examination. The details are presented in Table 2. As shown, there are differences between FNAB and histopathologic results for each diagnosis.
Table 2. Comparison of nodule characteristics based on FNAB and histopathology.
| Diagnosis | Classification | Fine-needle aspiration biopsy | Histopathology |
|---|---|---|---|
| Number of cases (n) | Number of cases (n) | ||
| Non-malignance | Follicular neoplasm | 5 | 0 |
| Follicular adenoma | 1 | 19 | |
| Papillary adenoma | 0 | 1 | |
| Non-neoplasm | Adenomatous goiter | 31 | 27 |
| Colloid goiter | 15 | 9 | |
| Cystic disease | 18 | 1 | |
| Hashimotos thyroiditis | 0 | 2 | |
| Nodular goiter | 0 | 1 | |
| Simple goiter | 1 | 0 | |
| Thyroglossal cyst | 0 | 1 | |
| Reactive hyperplasia | 1 | 0 | |
| Malignance | Papillary adenocarcinoma | 5 | 9 |
| Follicular adenocarcinoma | 3 | 3 | |
| Papillary carcinoma | 1 | 4 | |
| Follicular carcinoma | 1 | 3 | |
| Invasive papillary | 0 | 2 | |
| Adenocarcinoma | 0 | 0 | |
| Metastasis follicular | 1 | 0 |
Diagnostic ability of FNAB compared to histopathology
The sensitivity, specificity, PPV, and NPV were calculated using a fourfold table analysis (Table 3). Slight inconsistencies exist between FNAB and histopathologic results. Nine out of ten positive carcinoma results in FNAB and histopathology were confirmed, while one turned negative in histopathology. Surprisingly, 12 negative results from FNAB were positive in histopathology, while the majority of cases (n=61) showed consistent negative results in both FNAB and histopathology (Table 3).
Table 3. Fourfold analysis of diagnostic accuracy of FNAB and histopathology.
| Histopathology | |||
|---|---|---|---|
| Positive thyroid carcinoma (n) | Negative thyroid carcinoma (n) | ||
| FNAB | Positive thyroid carcinoma (n) | 9 | 1 |
| Negative thyroid carcinoma (n) | 12 | 61 | |
Based on a fourfold analysis of FNAB compared to histopathology examination, the sensitivity, specificity, PPV, and NPV were 42.85%, 98.38%, 90.00%, and 83.56%, respectively. The ROC curve was calculated, and results showed a diagnostic accuracy of 84.33% from comparing FNAB to histopathologic examination (Figure 1).
Figure 1. The receiver operating characteristic (ROC) curve shows diagnostic accuracy by comparing FNAB to histopathology.
Discussion
Thyroid nodules larger than 4 cm present a significant challenge in terms of diagnostic accuracy for appropriate management, given the fact that this study showed conflicting results from comparing FNAB to postoperative histopathology in detecting malignancy. This and previous studies [2,5,11,18,24,27,28] have demonstrated that FNAB may have the ability to distinguish malignancy in thyroid nodules larger than 4 cm, with varying sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy values.
The results from preoperative FNAB in this study are in line with previous studies, highlighting the lower sensitivity and higher false negativity rate of FNAB in larger nodules [2,18,24,27,28]. A study conducted found that there was an overall discrepancy rate of 15.3% between cytologic and histologic diagnoses [3]. Although FNAB can accurately detect large thyroid nodules, it has limited capability in distinguishing malignancies.
Previous studies have shown false negativity rates ranging from 7.7% to as high as 50% in nodules larger than 4 cm [2,3,5,12,15,24,27,28]. Three studies reported that the false negativity rates of 10.4% to 20% [5,11,13]. McCoy et al. demonstrated an unacceptably high false negativity rate of 13%, which increased to 16% when multifocal micropapillary carcinomas were included [12]. In addition, an unexpected finding by Koo et al. revealed a remarkably high false negativity rate of 50% in thyroid nodules larger than 4 cm [15]. These findings suggest that relying solely on FNAB results may lead to missed malignancies, necessitating the consideration of thyroidectomy even in cases with benign biopsy results.
Despite the reported high false negativity rates, conflicting studies have presented alternative perspectives. Kuru et al. reported similar false negativity rates for nodules smaller and larger than 4 cm (1.3% and 4.3%, respectively), indicating that the size of the nodule may not significantly influence FNAB accuracy [18]. Additionally, Albuja-Cruz et al. also found that the diagnostic reliability of FNAB is not affected by nodule size [22]. Rosario et al. suggested that the false negativity rate of 3.6% in nodules ≥4 cm does not justify routine surgery [19]. These distinct findings emphasize the need for a thorough assessment of various factors before deciding on thyroidectomy.
It is important to note that the accuracy of FNAB results can be influenced by various factors, including sample volume sufficiency, sampling from the correct site, and the accurate interpretation of the results [2,14,23,29]. Furthermore, the sensitivity of FNAB can be considerably impacted by pathologists’ competence in high-volume centers, as well as the quality of training and experience of operators at a particular facility [30]. Therefore, when advising patients about the necessity of thyroidectomy for large nodules, these factors should be taken into consideration and thoroughly discussed to ensure informed decision-making.
The recommendation of thyroidectomy can pose challenges for certain patients with large nodules, particularly those who have reduced life expectancies due to age or comorbidities, or for whom surgery may present significant health risks or financial burdens [24]. It is important to acknowledge that thyroid surgery is a complex procedure associated with potential complications. The extent of surgery and the surgeon’s experience both contribute to determining the risk of surgical complications, with total thyroidectomy carrying a higher risk compared to unilateral lobectomy [24]. The decline in quality of life after surgery can be impacted by a variety of factors, including the requirement for long-term medication, hypoparathyroidism, dysphagia, and dysphonia, which can be temporary or permanent [31]. Hence, the decision to remove large thyroid nodules should be carefully evaluated, taking into account individual patient factors and considerations.
Conclusion
Preoperative FNAB is a reliable diagnostic tool in the preoperative evaluation of thyroid nodules larger than 4 cm. Although FNAB can accurately detect large thyroid nodules, it has limited capability in distinguishing malignancies. Our results suggest that FNAB may be useful in reducing unnecessary surgeries; however, histopathology remains the preferred method for confirming malignancy in thyroid nodules.
Acknowledgments
We would like to express our gratitude to all patients included in this study.
Ethics approval
This study was approved by the Health Research Ethics Committee of Dr. Zainoel Abidin HospitalBanda Aceh, Indonesia (No 312/EA/FK-RSUDZA/2019).
Competing interests
The authors declare that there is no conflict of interest.
Funding
This study did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Underlying data
Derived data supporting the findings of this study are available from the first author on request.munication
How to cite
Zufry H, Nazaruddin, Zulfa PO, et al. Comparative analysis of accuracy between fine-needle aspiration biopsy and postoperative histopathology for detecting large thyroid nodules: A retrospective observational study. Narra J 2023; 3 (2): e206 - http://doi.org/10.52225/narra.v3i2.206.
References
- 1.Lee MK, Na DG, Joo L, et al. Standardized imaging and reporting for thyroid ultrasound: Korean Society of Thyroid Radiology Consensus Statement and Recommendation. Korean J Radiol 2023;24(1):22!30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Karadeniz E, Yur M, Temiz A, et al. Malignancy risk for thyroid nodules larger than 4 cm and diagnostic reliability of ultrasound-guided FNAB results. Turk J Surg 2019;35(1):13–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Yang J, Schnadig V, Logrono R, et al. Fine-needle aspiration of thyroid nodules: A study of 4703 patients with histologic and clinical correlations. Cancer 2007;111(5):306–315. [DOI] [PubMed] [Google Scholar]
- 4.Brito JP, Yarur AJ, Prokop LJ, et al. Prevalence of thyroid cancer in multinodular goiter versus single nodule: A systematic review and meta-analysis. Thyroid 2013;23(4):449–455. [DOI] [PubMed] [Google Scholar]
- 5.Kim JH, Kim NK, Oh YL, et al. The validity of ultrasonography-guided fine needle aspiration biopsy in thyroid nodules 4 cm or larger depends on ultrasonography characteristics. Endocrinol Metab 2014;29(4):545!552. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Pantanowitz L, Thompson LDR, Jing X, et al. Is thyroid core needle biopsy a valid compliment to fine-needle aspiration? J Am Soc Cytopathol 2020;9(5):383–388. [DOI] [PubMed] [Google Scholar]
- 7.Hahn SY, Shin JH, Oh YL, et al. Comparison between fine needle aspiration and core needle biopsy for the diagnosis of thyroid nodules: effective indications according to US Findings. Sci Rep 2020;10(1):4969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Gul K, Ersoy R, Dirikoc A, et al. Ultrasonographic evaluation of thyroid nodules: Comparison of ultrasonographic, cytological, and histopathological findings. Endocrine 2009;36(3):464–472. [DOI] [PubMed] [Google Scholar]
- 9.Seningen JL, Nassar A, Henry MR. Correlation of thyroid nodule fine-needle aspiration cytology with corresponding histology at Mayo Clinic, 2001-2007: An institutional experience of 1,945 cases. Diagn Cytopathol 2012;40:E27–32. [DOI] [PubMed] [Google Scholar]
- 10.Renshaw AA. Sensitivity of fine-needle aspiration for papillary carcinoma of the thyroid correlates with tumor size. Diagn Cytopathol 2011;39(7):471–474. [DOI] [PubMed] [Google Scholar]
- 11.Wharry LI, McCoy KL, Stang MT, et al. Thyroid nodules (≥4 cm): Can ultrasound and cytology reliably exclude cancer? World J Surg 2014;38(3):614–621. [DOI] [PubMed] [Google Scholar]
- 12.McCoy KL, Jabbour N, Ogilvie JB, et al. The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size. Surgery 2007;142(6):837!844. [DOI] [PubMed] [Google Scholar]
- 13.Carrillo JF, Frias‐Mendivil M, Ochoa‐Carrillo FJ, et al. Accuracy of fine-needle aspiration biopsy of the thyroid combined with an evaluation of clinical and radiologic factors. Otolaryngol Head Neck Surg 2000;122(6):917–921. [DOI] [PubMed] [Google Scholar]
- 14.Giles WH, Maclellan RA, Gawande AA, et al. False negative cytology in large thyroid nodules. Ann Surg Oncol 2015;22(1):152–157. [DOI] [PubMed] [Google Scholar]
- 15.Koo DH, Song K, Kwon H, et al. Does tumor size influence the diagnostic accuracy of ultrasound-guided fine-needle aspiration cytology for thyroid nodules? Int J Endocrinol 2016;2016:3803647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Pinchot SN. Accuracy of fine-needle aspiration biopsy for predicting neoplasm or carcinoma in thyroid nodules 4 cm or larger. Arch Surg 2009;144(7):649”655. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Bestepe N, Ozdemir D, Tam AA, et al. Malignancy risk and false-negative rate of fine needle aspiration cytology in thyroid nodules ≥4.0 cm. Surgery 2016;160(2):405–412. [DOI] [PubMed] [Google Scholar]
- 18.Kuru B, Gulcelik NE, Gulcelik MA, et al. The false-negative rate of fine-needle aspiration cytology for diagnosing thyroid carcinoma in thyroid nodules. Langenbecks Arch Surg 2010;395(2):127–132. [DOI] [PubMed] [Google Scholar]
- 19.Rosario PW, Salles DS, Bessa B, et al. Low false-negative rate of cytology in thyroid nodules ≥4 cm. Arq Bras Endocrinol Metabol 2009;53(9):1143–1145. [DOI] [PubMed] [Google Scholar]
- 20.Raj MD, Grodski S, Woodruff S, et al. Diagnostic lobectomy is not routinely required to exclude malignancy in thyroid nodules greater than four centimetres. ANZ J Surg 2012;82:73–77. [DOI] [PubMed] [Google Scholar]
- 21.Shrestha M, Crothers BA, Burch HB. The impact of thyroid nodule size on the risk of malignancy and accuracy of fine-needle aspiration: A 10-year study from a single institution. Thyroid 2012;22(12):1251–1256. [DOI] [PubMed] [Google Scholar]
- 22.Albuja-Cruz MB, Goldfarb M, Gondek SS, et al. Reliability of fine-needle aspiration for thyroid nodules greater than or equal to 4 cm. J Surg Res 2013;181(1):6–10. [DOI] [PubMed] [Google Scholar]
- 23.Megwalu UC. Risk of malignancy in thyroid nodules 4 cm or larger. Endocrinol Metab 2017;32:77. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kulstad R. Do all thyroid nodules ≥4 cm need to be removed? An evaluation of thyroid fine-needle aspiration biopsy in large thyroid nodules. Endocr Pract 2016;22:791–7918. [DOI] [PubMed] [Google Scholar]
- 25.Yilmaz N, Cansu G, Toru S, et al. Cytopathology-histopathology correlation and the effect of nodule diameter on diagnostic performance in patients undergoing thyroid fine-needle aspiration biopsy. J Cancer Res Ther 2020;16:53! 58. [DOI] [PubMed] [Google Scholar]
- 26.Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid 2017;27:1341–1346. [DOI] [PubMed] [Google Scholar]
- 27.Sinna EA, Ezzat N.. Diagnostic accuracy of fine needle aspiration cytology in thyroid lesions. J Egypt Natl Canc Inst 2012;24(2):63–70. [DOI] [PubMed] [Google Scholar]
- 28.Godazandeh G, Kashi Z, Zargarnataj S, et al. Evaluation the relationship between thyroid nodule size with malignancy and accuracy of fine needle aspiration biopsy (FNAB). Acta Inform Med 2016;24(5):347–350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Mehanna R, Murphy M, McCarthy J, et al. False negatives in thyroid cytology: Impact of large nodule size and follicular variant of papillary carcinoma. Laryngoscope 2013;123(5):1305–1309. [DOI] [PubMed] [Google Scholar]
- 30.Yeh MW, Demircan O, Ituarte P, et al. False-negative fine-needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. Thyroid 2004;14(3):207–215. [DOI] [PubMed] [Google Scholar]
- 31.Chandrasekhar SS, Randolph GW, Seidman MD, et al. Clinical practice guideline: Improving voice outcomes after thyroid surgery. Otolaryngol Head Neck Surg 2013;148:S1–S37. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Derived data supporting the findings of this study are available from the first author on request.munication

